The efficacy and safety of IBI314 on delta and omicron variant of SARS-CoV-2: First-in-human evidence.
Sang L, Cheng B, Yu Y, Xi Y, Wang Y, Fan B, Li J, Dai J, Gan G, Tong S, Sun B, Qi X, Liang W, He J, Zhong N.
Sang L, et al. Among authors: wang y.
J Infect. 2022 Sep;85(3):334-363. doi: 10.1016/j.jinf.2022.06.004. Epub 2022 Jun 9.
J Infect. 2022.
PMID: 35691517
Free PMC article.
No abstract available.